Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. It operates through the following geographical segments: North America, Europe, Asia Pacific, and Other. The Other segment includes New Zealand, Latin America, Africa, and the Middle East. The company was founded in 1969 and is headquartered in Auckland, New Zealand.

Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy.

BioMerieux designs, develops, manufactures, and markets in vitro diagnostic systems for clinical and industrial applications. The company’s diagnostic systems consist of reagents and consumables used to conduct biological tests, for use in performing screening, diagnostic assistance, prognosis, and treatment monitoring; instruments, platforms, and autoanalyzers used for automated testing at high or low throughputs; software to process analyses and systems to interpret biological test results; and other related services such as the installation and maintenance of instruments, user training, and the audit of laboratory workflows. BioMerieux offers diagnostic systems for clinical applications including the diagnosis of infectious diseases, comprising HIV, tuberculosis, and respiratory diseases, as well as cardiovascular diseases and targeted cancers based on the analysis of biological samples such as blood, saliva, and urine; and for industrial applications including the analysis of microbiological manufacturing such as food, pharmaceuticals, and cosmetics. The company markets and sells its products through a network of distributors to private sector analysis laboratories, hospital laboratories, blood banks, and physician office laboratories; food, pharmaceutical, and cosmetics industries; and independent quality control laboratories. It has operations in Europe, the Middle East, Africa, North America, Asia-Pacific, and Latin America. BioMerieux were founded in 1963 and is headquartered in Marcy l’Etoile, France. It is a subsidiary of Institut Mérieux.

NasoGastric Feeding Solutions are dedicated to revolutionizing enteral access by providing clinicians with better tools to safely place lifesaving Naso/orogastric feeding and decompression tubes.

Part of Koninklijke Philips NV, RIC Investments LLC is a company headquartered in the United States. The firm designs, manufactures, and markets sleep and respiratory medical devices.

Fisher & Paykel Healthcare Ltd., part of Fisher & Paykel Healthcare Corp. Ltd., is a company headquartered in Auckland, New Zealand. The firm manufactures and sells products and systems for use in respiratory care, acute care, and the treatment of obstructive sleep apnea.

Guizhou Provincial People's Hospital is a private company headquartered in Guiyang, China, that provides medical services.

Hangzhou Aoguang Medical Equipment Co., Ltd., established on 2016-04-21, Business scope includes production,Sales:Class I,Class II,Class III medical device;Medical Device Repair;Processing hardware;Import and export of goods and technology.(law,Except for items prohibited by administrative regulations,Projects that are restricted by laws and regulations can only be operated after obtaining a license).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhejiang Tongxuan Medical Technology Co., Ltd., established on 2020-06-29, Business scope includes general items:Medical Research and Experimental Development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of labor protection products;Production of labor protection products;Wholesale of protective equipment for medical staff;Retailing of protective equipment for healthcare workers;Medical Mask Retail;Wholesale medical masks;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of protective equipment for medical personnel(Ι class medical device)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Class III medical device business;Production of Class III Medical Devices;Production of medical masks;Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal. - The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines. - The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies. - The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is headquartered in Deerfield, Illinois.

Entellus Medical is focused on providing unique solutions to the unmet needs of the ENT (ear, nose and throat) physician, their patients, and payers through the development of innovative device technology and treatment solutions. Entellus is based in Maple Grove, MN and markets products throughout the United States. Entellus Medical works closely with leading researchers and clinicians to develop solutions that benefit patients, physicians, and payers. Entellus provides a simple, direct and effective treatment for Chronic Rhinosinusitis (CRS) that is less invasive, reduces pain and bleeding, shortens recovery time, and eliminates the need for general anesthesia. Entellus recently introduced FinESSâ„¢ Sinus Treatment, a simple and direct approach to effectively treat patients with CRS. FinESS can be performed under local anesthesia, with or without light sedation, and remodels the maxillary ostium and the ethmoid infundibulum using a micro endoscope and a small balloon catheter. Unlike sinus surgery techniques, FinESS does not require the removal of delicate bone or sinus tissue, resulting in shorter treatment time with very little pain or bleeding. Recovery time is usually one to two days with many patients resuming normal activity within a day.

Shanghai Orientation Medical System Co., Ltd., established on 2004-05-12, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Production of Class I Medical Devices;Sell ​​self-produced products,And provide relevant technical consultation and after-sales technical services;Research,Develop drug delivery systems,cryogenic freezing,radio frequency,microwave,ultrasound,nuclear magnetic resonance,chemotherapy,Surgical Instruments,Surgical navigation and surgical positioning and other equipment required for various tumor diagnosis and treatment,Materials and Accessories,Transfer of own technological achievements,And provide related technical services,technical consulting;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Electrical Control Components,metal products,Wholesale of plastic products,import and export,commission agent(except auction),and provide related services(Commodities that do not involve state trade management,design quota,The application for license management products shall be handled in accordance with relevant state regulations);Medical equipment rental;Business Consulting(except financial information).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Kunshan Yuanshan Tiandi Software Technology Co., Ltd., established on 2016-03-30, Business scope includes software development,software design;Technology development in the computer field,technology transfer,technical consulting,Technical Services;Computer hardware and software,communication equipment(Does not include satellite broadcasting and TV ground receiving facilities)Sales;Non-administrative licensing business information consultation,Business Management Consulting,Enterprise Marketing Planning,marketing planning,Conference and exhibition services,Enterprise Management Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nippon Paper Group is a diversified international timber, pulp, paper, paperboard packaging and chemicals business with operations in Asia, Oceania, North and South America and Europe. Headquartered in Tokyo, Japan, Nippon Paper was founded in 1949 and is listed on the Tokyo Stock Exchange with net sales of approx. $15 billion AUD. Nippon Paper Group is committed to global expansion through its key growth areas of packaging, household paper and healthcare, chemicals, energy, and wood products. Past acquisitions have included Australian Paper in 2009 for approx. $700 million AUD and the Weyerhaeuser liquid packaging board business in 2016 for $285 million USD. The purchase of Orora's Australasian Fibre Packaging business will be the Group's largest investment outside Japan.

China Metallurgical Huatian Engineering Technology Co., Ltd., established on 2004-07-01, The scope of operation includes the undertaking country(territory)Internal and external metallurgical industry,achitechive,construction work,Civil Air Defense Engineering,Power Industry,Communication engineering of electronic communication radio and television industry,Municipal utilities(gas,heat,water supply,drainage,the way,bridge tunnel),Building Intelligent System Engineering,Environmental Pollution Prevention,Engineering Design for Urban Planning,project consultancy,Product development and technology transfer,Environmental Impact Assessment,EPC(Including processing,manufacture),Engineering cost consultation,Engineering bidding agency,computer software programming,System integration and complete supply of related equipment and materials.country of operation(territory)Import and export business of foreign mechanical and electrical products and raw materials,processing and"Three to one make up"And counter trade and re-export business.(Projects that require approval according to law can only be operated after being approved by relevant departments)

Maxi-Cosi provides car seats, strollers, and travel systems that are perfectly prepared for everything that motherhood has to offer. Every product and every function has been painstakingly created to assist customers and make their lives a little easier.

Beijing Dingdian Technology Co., Ltd., established on 2003-09-22, Business scope includes engineering survey,engineering design;Professional contractors;technology development,technical consulting,Technical Services,technology transfer;sell electronics,Equipment,household appliances,Security Technology Protection Products,Wujinjiaodian(E-bike not included),computer,Software and Auxiliary Equipment,sporting goods,daily necessities,lamps,photographic equipment,communication equipment,stationery,furniture(Not engaged in physical store operation),Glasses,clothing,metallic material,shoes and hats,bags,knitted goods,car,medical instrumentsIkind,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals);Construction Project Management;Machinery and Equipment Leasing(Car rental not included);Instrument Repair;Computer System Services.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Engineering Investigation,Engineering design and projects subject to legal approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)